Miragen Therapeutics Inc (MGEN) Stock Price, Quote, News and Overview
NASDAQ:MGEN - Nasdaq -
MGEN Quote, Performance and Key Statistics
NASDAQ:MGEN (1/19/2021, 8:20:36 PM)
23.01
-0.02 (-0.09%)
The current stock price of MGEN is 23.01 null. In the past month the price increased by 15.69%. In the past year, price increased by 58.14%.
About MGEN
Company Profile
Miragen Therapeutics, Inc. is a biopharmaceutical company. It develops microRNA biology, oligonucleotide chemistry, drugs and therapies for cancer, pathologic fibrosis, neuro-inflammatory and cardiovascular diseases. Miragen Therapeutics, Inc., formerly known as Signal Genetics, is headquartered in Boulder, Colorado.
Company Info
Miragen Therapeutics Inc
6200 LOOKOUT ROAD
BOULDER CO 80301
CEO: William S. Marshall
Phone: 720-643-5200
Miragen Therapeutics Inc / MGEN FAQ
What is the stock price of Miragen Therapeutics Inc today?
The current stock price of MGEN is 23.01 null. The price decreased by -0.09% in the last trading session.
What is the ticker symbol for Miragen Therapeutics Inc stock?
The exchange symbol of Miragen Therapeutics Inc is MGEN and it is listed on the Nasdaq exchange.
On which exchange is MGEN stock listed?
MGEN stock is listed on the Nasdaq exchange.
What is Miragen Therapeutics Inc worth?
Miragen Therapeutics Inc (MGEN) has a market capitalization of 89.92M null. This makes MGEN a Micro Cap stock.
What are the support and resistance levels for Miragen Therapeutics Inc (MGEN) stock?
Miragen Therapeutics Inc (MGEN) has a support level at 19.31 and a resistance level at 23.03. Check the full technical report for a detailed analysis of MGEN support and resistance levels.
Should I buy Miragen Therapeutics Inc (MGEN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MGEN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MGEN, evaluating the profitability, health, valuation and growth aspects
- Miragen Therapeutics Inc (MGEN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Miragen Therapeutics Inc (MGEN) Sales and EPS estimates to see what analysts future expectations are.
- Miragen Therapeutics Inc (MGEN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Miragen Therapeutics Inc (MGEN) Insider and Institutional Ownership to learn about the owners and their transactions.
- Miragen Therapeutics Inc (MGEN) Stock Chart to make your own analysis
- Miragen Therapeutics Inc (MGEN) Latest news and press-releases to stay up to date.
Does Miragen Therapeutics Inc (MGEN) stock pay dividends?
MGEN does not pay a dividend.
What is the Price/Earnings (PE) ratio of Miragen Therapeutics Inc (MGEN)?
Miragen Therapeutics Inc (MGEN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-10.65).
MGEN Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to MGEN. When comparing the yearly performance of all stocks, MGEN is one of the better performing stocks in the market, outperforming 94.92% of all stocks.
MGEN Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MGEN. MGEN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
MGEN Financial Highlights
Over the last trailing twelve months MGEN reported a non-GAAP Earnings per Share(EPS) of -10.65. The EPS decreased by -1.82% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -1604% | ||
| ROA | -91.65% | ||
| ROE | N/A | ||
| Debt/Equity | 0.2 |
MGEN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 90% to MGEN. The Buy consensus is the average rating of analysts ratings from 4 analysts.